DNA methyltransferase 3, a target of microRNA-29c, contributes to neuronal proliferation by regulating the expression of brain-derived neurotrophic factor

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 1435-1442

  Yang, Guoshuai ^a,b   Song, Yanmin ^c   Zhou, Xiaoyan ^b   Deng, Yidong ^a   Liu, Tao ^a   Weng, Guohu ^a   Yu, Dan ^b   Pan, Suyue ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b HAIKOU PEOPLE S HOSPITAL   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Brain derived neurotrophic factor; DNA methyltransferase; Extracellular signal regulated kinase; MicroRNA; Tyrosine receptor kinase B

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3; MICRORNA 29; MICRORNA 29C; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; AZACITIDINE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A; MICRORNA; MIRN29 MICRORNA, HUMAN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; EMBRYO; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ALZHEIMER DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; CELL SURVIVAL; CEREBROSPINAL FLUID; DNA METHYLATION; GENETICS; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; AZACITIDINE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL PROLIFERATION; CELL SURVIVAL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEURONS; PRIMARY CELL CULTURE; RATS; SIGNAL TRANSDUCTION;

EID: 84926637103     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3531     Document Type: Article

References (32)

1. Kim DH, Yeo SH, Park JM, et al: Genetic markers for diagnosis and pathogenesis of Alzheimer's disease. Gene 545: 185-193, 2014.
2. Morales I, Guzmán-Martínez L, Cerda-Troncoso C, Farías GA and Maccioni RB: Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci 8: 112, 2014.
3. Dunkel P, Chai CL, Sperlágh B, Huleatt PB and Mátyus P: Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases and amyotrophic lateral sclerosis. Expert Opin Investig Drugs 21: 1267-1308, 2012.
4. García-Mesa Y, Pareja-Galeano H, Bonet-Costa V, et al: Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms. Psychoneuroendocrinology 45: 154-166, 2014.
5. Li G, Peskind ER, Millard SP, et al: Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One 4: e5424, 2009.
6. Keleshian VL, Modi HR, Rapoport SI and Rao JS: Aging is associated with altered inflammatory, arachidonic acid cascade and synaptic markers, influenced by epigenetic modifications, in the human frontal cortex. J Neurochem 125: 63-73, 2013.
7. Walker MP, LaFerla FM, Oddo SS and Brewer GJ: Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease. Age (Dordr) 35: 519-531, 2013.
8. Mastroeni D, Chouliaras L, Grover A, et al: Reduced RAN expression and disrupted transport between cytoplasm and nucleus; a key event in Alzheimer's disease pathophysiology. PLoS One 8: e53349, 2013.
9. Bihaqi SW, Huang H, Wu J and Zawia NH: Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: implications for Alzheimer's disease. J Alzheimers Dis 27: 819-833, 2011.
10. Fuso A, Nicolia V, Cavallaro RA and Scarpa S: DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models. J Nutr Biochem 22: 242-251, 2011.
11. Imai S, Saeki M, Yanase M, et al: Change in microRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain. J Neurosci 31: 15294-15299, 2011.
12. Pereira P, Sousa Â, Queiroz J, Correia I, Figueiras A and Sousa F: Purification of pre-miR-29 by arginine-affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci, 951-952: 16-23, 2014.
13. Zhang J, Hu M, Teng Z, Tang YP and Chen C: Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease. J Neurosci 34: 14919-14933, 2014.
14. Kong Y, Wu J and Yuan L: MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model. Curr Alzheimer Res 11: 882-891, 2014.
15. Pogue AI, Hill JM and Lukiw WJ: MicroRNA (miRNA): Sequence and stability, viroid-like properties and disease association in the CNS. Brain Res 1584: 73-79, 2014.
16. Spencer P, Fry RC and Kisby GE: Unraveling 50-year-old Clues linking Neurodegeneration and cancer to Cycad Toxins: Are microRNAs common mediators? Front Genet 3: 192, 2012.
17. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
18. Harvey PD: Clinical applications of neuropsychological assessment. Dialogues Clin Neurosci 14: 91-99, 2012.
19. Lista S, Zetterberg H, Dubois B, Blennow K and Hampel H: Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments. J Neurol 261: 1234-1243, 2014.
20. Peng S, Wuu J, Mufson EJ and Fahnestock M: Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93: 1412-1421, 2005.
21. Laske C, Stellos K, Hoffmann N, et al: Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. Int J Neuropsychopharmacol 14: 399-404, 2011.
22. Laske C, Stransky E, Leyhe T, et al: BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. J Psychiatr Res 41: 387-394, 2007.
23. Subramaniam D, Thombre R, Dhar A and Anant S: DNA Methyltransferases: a novel target for prevention and therapy. Front Oncol 4: 80, 2014.
24. Boersma GJ, Lee RS, Cordner ZA, et al: Prenatal stress decreases Bdnf expression and increases methylation of Bdnf exon IV in rats. Epigenetics 9: 437-447, 2014.
25. Guo X, Wu X, Ren L, Liu G and Li L: Epigenetic mechanisms of amyloid-beta production in anisomycin-treated SH-SY5Y cells. Neuroscience 194: 272-281, 2011.
26. Zhang J, Sokal I, Peskind ER, et al: CSF multianalyte profile distinguishes Alzheimer and Parkinson disease. Am J Clin Pathol 129: 526-529, 2008.
27. Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H and Miyazawa T: MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. J Alzheimers Dis 39: 253-259, 2014.
28. Wang WX, Huang Q, Hu Y, Stromberg AJ and Nelson PT: Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 121: 193-205, 2011.
29. Pandey M, Sultana S and Gupta KP: Involvement of epigenetics and microRNA-29b in the urethane induced inception and establishment of mouse lung tumors. Exp Mol Pathol 96: 61-70, 2014.
30. Tong L, Balazs R, Thornton PL and Cotman CW: Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci 24: 6799-6809, 2004.
31. Jeronimo-Santos A, Vaz SH, Parreira S, et al: Dysregulation of TrkB receptors and BDNF function by Amyloid-β Peptide is mediated by Calpain. Cereb Cortex, 2014.
32. Liu Y, Tao L, Fu X, Zhao Y and Xu X: BDNF protects retinal neurons from hyperglycemia through the TrkB/ERK/MAPK pathway. Mol Med Rep 7: 1773-1778, 2013.